» Articles » PMID: 22747566

NADPH Oxidases in Heart Failure: Poachers or Gamekeepers?

Overview
Specialty Endocrinology
Date 2012 Jul 4
PMID 22747566
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Significance: Oxidative stress is involved in the pathogenesis of heart failure but clinical antioxidant trials have been unsuccessful. This may be because effects of reactive oxygen species (ROS) depend upon their source, location, and concentration. Nicotinamide adenine dinucleotide phosphate oxidase (Nox) proteins generate ROS in a highly regulated fashion and modulate several components of the heart failure phenotype.

Recent Advances: Two Nox isoforms, Nox2 and Nox4, are expressed in the heart. Studies using gene-modified mice deficient in Nox2 activity indicate that Nox2 activation contributes to angiotensin II-induced cardiomyocyte hypertrophy, atrial fibrillation, and the development of interstitial fibrosis but may also positively modulate physiological excitation-contraction coupling. Nox2 contributes to myocyte death under stress situations and plays important roles in postmyocardial infarction remodeling, in part by modulating matrix metalloprotease activity. In contrast to Nox2, Nox4 is constitutively active at a low level and induces protective effects in the heart under chronic stress, for example, by maintaining myocardial capillary density. However, high levels of Nox4 could have detrimental effects.

Critical Issues: The effects of Nox proteins during the development of heart failure likely depend upon the isoform, activation level, and cellular distribution, and may include beneficial as well as detrimental effects. More needs to be learnt about the precise regulation of abundance and biochemical activity of these proteins in the heart as well as the downstream signaling pathways that they regulate.

Future Directions: The development of specific approaches to target individual Nox isoforms and/or specific cell types may be important for the achievement of therapeutic efficacy in heart failure.

Citing Articles

Hypertension toxicity of VEGFR-TKIs in cancer treatment: incidence, mechanisms, and management strategies.

Du Y, Li X, Ji S, Niu N Arch Toxicol. 2024; 99(1):67-81.

PMID: 39347999 DOI: 10.1007/s00204-024-03874-4.


The NADPH oxidase inhibitor diphenyleneiodonium suppresses Ca signaling and contraction in rat cardiac myocytes.

Le Q, Trinh T, Luong P, Anh V, Tran H, Kim J Korean J Physiol Pharmacol. 2024; 28(4):335-344.

PMID: 38926841 PMC: 11211754. DOI: 10.4196/kjpp.2024.28.4.335.


Vitamin C as Scavenger of Reactive Oxygen Species during Healing after Myocardial Infarction.

Zheng H, Xu Y, Liehn E, Rusu M Int J Mol Sci. 2024; 25(6).

PMID: 38542087 PMC: 10970003. DOI: 10.3390/ijms25063114.


NADPH oxidase 2 mediates cardiac sympathetic denervation and myocyte autophagy, resulting in cardiac atrophy and dysfunction in doxorubicin-induced cardiomyopathy.

Ma Y, Zhao H, Yang L, Li L, Wang A, Zhang X Sci Rep. 2024; 14(1):6971.

PMID: 38521855 PMC: 10960835. DOI: 10.1038/s41598-024-57090-2.


Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review).

Chen B, Guo J, Ye H, Wang X, Feng Y Mol Med Rep. 2024; 29(5).

PMID: 38488029 PMC: 10955520. DOI: 10.3892/mmr.2024.13197.


References
1.
Bedard K, Krause K . The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007; 87(1):245-313. DOI: 10.1152/physrev.00044.2005. View

2.
Zeng Q, Zhou Q, Yao F, ORourke S, Sun C . Endothelin-1 regulates cardiac L-type calcium channels via NAD(P)H oxidase-derived superoxide. J Pharmacol Exp Ther. 2008; 326(3):732-8. PMC: 4323092. DOI: 10.1124/jpet.108.140301. View

3.
Ago T, Kuroda J, Pain J, Fu C, Li H, Sadoshima J . Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res. 2010; 106(7):1253-64. PMC: 2855780. DOI: 10.1161/CIRCRESAHA.109.213116. View

4.
Doughan A, Harrison D, Dikalov S . Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2007; 102(4):488-96. DOI: 10.1161/CIRCRESAHA.107.162800. View

5.
Sorescu D, Weiss D, Lassegue B, Clempus R, Szocs K, Sorescu G . Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation. 2002; 105(12):1429-35. DOI: 10.1161/01.cir.0000012917.74432.66. View